MAIA Biotechnology Correlations

MAIA Stock  USD 2.20  0.02  0.92%   
The current 90-days correlation between MAIA Biotechnology and Lineage Cell Therapeutics is 0.17 (i.e., Average diversification). The correlation of MAIA Biotechnology is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.

MAIA Biotechnology Correlation With Market

Average diversification

The correlation between MAIA Biotechnology and DJI is 0.12 (i.e., Average diversification) for selected investment horizon. Overlapping area represents the amount of risk that can be diversified away by holding MAIA Biotechnology and DJI in the same portfolio, assuming nothing else is changed.
  
Check out Correlation Analysis to better understand how to build diversified portfolios, which includes a position in MAIA Biotechnology. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in gross domestic product.
For information on how to trade MAIA Stock refer to our How to Trade MAIA Stock guide.

Moving together with MAIA Stock

  0.63JNJ Johnson Johnson Fiscal Year End 28th of January 2025 PairCorr
  0.68TAK Takeda PharmaceuticalPairCorr
  0.65INMB INmune BioPairCorr
  0.7ABBV AbbVie IncPairCorr
  0.74AMGN Amgen IncPairCorr

Moving against MAIA Stock

  0.69BMY Bristol Myers Squibb Aggressive PushPairCorr
  0.63ESPR Esperion TherapeuticsPairCorr
  0.53VTRS ViatrisPairCorr
  0.53EWTX Edgewise TherapeuticsPairCorr
  0.49BCTXW BriaCell TherapeuticsPairCorr
  0.44GILD Gilead SciencesPairCorr
  0.39BHC Bausch Health CompaniesPairCorr
  0.37WAT WatersPairCorr
  0.35BFRIW Biofrontera WarrantsPairCorr
  0.33EBS Emergent BiosolutionsPairCorr
  0.33GANX Gain TherapeuticsPairCorr
  0.67BSX Boston Scientific CorpPairCorr
  0.58DXCM DexCom IncPairCorr
  0.4MNMD Mind MedicinePairCorr
  0.39EW Edwards Lifesciences CorpPairCorr

Related Correlations Analysis

Click cells to compare fundamentals   Check Volatility   Backtest Portfolio

Correlation Matchups

Over a given time period, the two securities move together when the Correlation Coefficient is positive. Conversely, the two assets move in opposite directions when the Correlation Coefficient is negative. Determining your positions' relationship to each other is valuable for analyzing and projecting your portfolio's future expected return and risk.
High positive correlations   
LYRALCTX
GNLXLRMR
LYRALRMR
GNLXAGE
CMRAGRPH
LRMRARMP
  
High negative correlations   
FREQLCTX
GRPHAGE
CMRAGNLX
LYRAFREQ
LRMRFREQ
FREQARMP

Risk-Adjusted Indicators

There is a big difference between MAIA Stock performing well and MAIA Biotechnology Company doing well as a business compared to the competition. There are so many exceptions to the norm that investors cannot definitively determine what's good or bad unless they analyze MAIA Biotechnology's multiple risk-adjusted performance indicators across the competitive landscape. These indicators are quantitative in nature and help investors forecast volatility and risk-adjusted expected returns across various positions.
Mean DeviationJensen AlphaSortino RatioTreynor RatioSemi DeviationExpected ShortfallPotential UpsideValue @RiskMaximum Drawdown
LCTX  3.66 (0.79) 0.00 (0.25) 0.00 
 7.14 
 39.60 
ARMP  3.08 (0.01)(0.02) 0.09  3.74 
 6.19 
 33.83 
FREQ  4.38  0.84  0.11 (0.60) 3.90 
 5.71 
 90.18 
PRTG  8.49  0.55  0.03 (0.46) 10.63 
 10.92 
 134.05 
AGE  4.46  0.48  0.07  1.02  4.99 
 8.20 
 47.55 
LRMR  4.15 (0.37) 0.00 (0.08) 0.00 
 10.87 
 26.71 
GRPH  2.36 (0.13) 0.00 (0.39) 0.00 
 4.79 
 14.40 
LYRA  4.16 (0.78) 0.00 (0.48) 0.00 
 8.00 
 41.07 
GNLX  4.73  0.52  0.08  0.99  5.14 
 13.94 
 40.11 
CMRA  5.99 (0.20) 0.00 (0.01) 0.00 
 13.95 
 30.28 

MAIA Biotechnology Corporate Management

MD MBAPresident, CoFounderProfile
Joseph McGuireChief OfficerProfile
Sergei GryaznovChief OfficerProfile
Jeffrey HimmelreichHead FinanceProfile
Mihail MDChief DevelProfile
Linda MoreiraCompany SecretaryProfile